Beverly Plunkett

21 papers receiving 5.8k citations

Beverly Plunkett's Hit Papers

Wild-type p53 is a cell cycle checkpoint determinant following irradiation. 1992 · 1.6k citations
1.6k0+11+22Years since publication50010001.5k2.0k2.5k

Peers

Beverly Plunkett
Comparison fields: 5 of 106
  • Oncology 3.7k
  • Biotechnology 1.0k
  • Cancer Research 1.0k
  • Molecular Biology 3.8k
  • Immunology and Allergy 239
Replace Takashi Tokino with:
Takashi Tokino Japan
Prem Seth United States
Richard A. Ashmun United States
Rob Michalides Netherlands
R W Craig United States
Jiří Lukáš Denmark
W E Mercer United States
Helge Täubert Germany
Rama Modali United States
Masatoshi Tagawa Japan
Beverly Plunkett relative to Takashi Tokino Japan Takashi Tokino's profile →
Citations per field
00.5×1.5×2.3×
Takashi Tokino · 1×
Citations per year

Countries citing papers authored by Beverly Plunkett

Since Specialization
Citations

This map shows the geographic impact of Beverly Plunkett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Plunkett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Plunkett more than expected).

Fields of papers citing papers by Beverly Plunkett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly Plunkett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Plunkett. The network helps show where Beverly Plunkett may publish in the future.

Co-authors

The 25 scholars most cited alongside Beverly Plunkett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beverly Plunkett Line = papers co-authored together Beverly Plunkett links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Hit paper breakdown →
19922660
2
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Hit paper breakdown →
19921597
3 1993443
4 1994293
5 2000217
6 201099
7 200479
8 200474
9 201074
10 201370
11 200562
12 201457
13 201345
14 200634
15 200725
16 200324
17 201419
18 201317
19 200916
20 200514

About Beverly Plunkett

Beverly Plunkett is a scholar working on Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Physiology, having authored 22 papers that have together received 5.9k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (5 papers), Immune Cell Function and Interaction (4 papers), Cancer-related Molecular Pathways (4 papers), Bone and Dental Protein Studies (3 papers), Immunotherapy and Immune Responses (3 papers), Neonatal Respiratory Health Research (3 papers), Allergic Rhinitis and Sensitization (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Oncology (3.7k citations), Biotechnology (1.0k citations), Cancer Research (1.0k citations), Molecular Biology (3.8k citations) and Immunology and Allergy (239 citations). Beverly Plunkett has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include William Walsh, Michael B. Kastan, Steven J. Kuerbitz, Tyler Jacks, Wafik S. El‐Deiry, France Carrier, Albert J. Fornace, B Vogelstein, Theodore D. Kessis and Robert J.C. Slebos. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Journal of Interferon & Cytokine Research, Proceedings of the National Academy of Sciences, The Journal of Immunology and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact